person

Olga S.

Country
Austria
Department
Oncology/Haematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
6
Sites with multiple studies

Has run more than one trial at 6 of 62 partner sites.

Specializations

Lymphoma Treatment

The investigator specializes in treating complex lymphoid malignancies, with particular emphasis on mantle cell lymphoma and follicular lymphoma. Their research explores innovative therapeutic approaches for patients who have undergone previous treatments.

  • Mantle Cell Lymphoma Management
  • Follicular B-cell Non-Hodgkin Lymphoma
  • Refractory Disease Treatment

Their expertise extends to grade 1-3A lymphomas requiring advanced therapeutic interventions.

Novel Therapeutic Approaches

The investigator focuses on evaluating cutting-edge treatments including BTK inhibitor therapy and tisagenlecleucel treatment. Their work encompasses comparing innovative therapies against established standard of care protocols.

  • Targeted Molecular Therapies
  • Bruton's Tyrosine Kinase Inhibition
  • Advanced Cellular Therapies

Their research interests include monotherapy approaches and comparative treatment strategies.

Treatment Outcomes

The investigator evaluates progression-free survival in lymphoma patients through systematic assessment protocols. Their work involves detailed analysis of treatment responses using established clinical criteria.

  • Response Assessment
  • Survival Outcomes
  • Treatment Efficacy Evaluation

Their research incorporates independent review committee assessments and standardized response criteria.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.